Some new TIBO-like derivatives have been designed by contraction of the β-ring (diazepine ring) of TIBO derivatives from seven to 6-membered ring.
Similarly, hydroxylation of the β-ring of α-carotene produces zeinoxanthin, and subsequent hydroxylation of the ε-ring yields lutein.
The most likely scenario is that LUT1 has a higher affinity towards ε-rings vs. β-rings and that, when α-carotene is available, LUT1 performs mainly ε-ring hydroxylation; however, since no ε-ring-substrates are available in the chy1chy2lut2lut5, the β-ring substrates are processed, thus bringing out this minor activity of the enzyme.
Hydroxylation of one β-carotene ring produces β-cryptoxanthin followed by hydroxylation of the other β-ring to produce zeaxanthin.
The first contact pair was between the first sealing ring and external surface of the pipeline, the second one was between the second sealing ring and external surface of the pipeline, the third one was between the first convex ring and internal surface of the press ring and the forth one was between the second convex ring and internal surface of the press ring.
In fact, the surface of the outer ring has a sub-nanometre surface roughness.
The addition of a β-ring and an ε-ring forms the β,ε branch of carotenoids, including α-carotene and its derivatives; the formation of two β-rings creates the β,β branch of carotenoids, containing β-carotene and its derivatives.
Crucially, not only did ring assembly mutations disrupt secretion, but variants containing mutations on the inner surface of the ring considerably affected protein export, suggesting that the route through the SctV ring is the path toward secretion.
To avoid any misinterpretation, the aorta rings were evaluated only if the entire surface of the ring was present.
The talar wires are placed 8 10 mm above the cranial surface of the horseshoe-shaped ring.
